Clinical Trials
51 trialsNatural History Study of Patients With Neurofibromatosis Type 2
National Institutes of Health Clinical Center (CC)
Cognitive Status After Removal of Skull Base Meningioma
Ohio State University
CSF-IMR
Medical University of Warsaw
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
FET-BRAIN-DX
IRCCS San Raffaele
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
University of California, San Francisco
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
CoDeB-Rad
University of Nottingham
PROTONBIOMARKS
Centre Leon Berard
MiDura
Aesculap AG
GM-HES
Chiang Mai University
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
GT Medical Technologies, Inc.
MIND
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
MenQOL 2
Centre Hospitalier St Anne
MENTHE
Fondation Ophtalmologique Adolphe de Rothschild
CAMOMILLE
Fondation Ophtalmologique Adolphe de Rothschild
LIBERATE
University Health Network, Toronto
PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI
Maastricht Radiation Oncology
EURJMT
University Hospital Muenster
MenQOL
Centre Hospitalier St Anne
MELUTE
Central Hospital, Nancy, France
Endo-Olfact
Universitaire Ziekenhuizen KU Leuven
SSTR
Central Hospital, Nancy, France
DATUM
Central Hospital, Nancy, France
SOLOMON
Seoul National University Hospital
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Maastricht Radiation Oncology
Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow
Dynamic Light
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
University of California, San Diego
MethylRH-M
Central Hospital, Nancy, France
Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas
IRCCS San Raffaele
177Lumen
Central Hospital, Nancy, France
ANDROMEDE-F
Assistance Publique - Hôpitaux de Paris
Establishment and Characterization of Meningioma Patient-derived Organoids
Chinese University of Hong Kong
Cognition-preserving Brain Irradiation for Treating Patients With Intracranial Meningioma in the Era of Modern Radiotherapeutic Techniques Including Proton Beam Therapy - a Prospective Study Focusing on Radiological Outcomes and Neurocognitive Endpoints
Chang Gung Memorial Hospital
MEME
Assistance Publique - Hôpitaux de Paris
ATYPICMENING
University Hospital, Montpellier
Automated Segmentation and Volumetry for Meningioma Using Deep Learning
Seoul National University Hospital
MuRaLM
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Sphenoorbital Meningioma Management.
Assiut University
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Case Comprehensive Cancer Center
MAP
University Hospital, Brest
Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy
Weill Medical College of Cornell University
A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery
St. Olavs Hospital
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Wake Forest University Health Sciences
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
University Hospital, Montpellier
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
Children's Oncology Group
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Children's Oncology Group
The Etiology and Progression of Brain Tumors
Tampere University Hospital
Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Marquette General Health System
Analysis of NF2 Mutations in Radiation-Related Neural Tumors
National Institutes of Health Clinical Center (CC)